Royal Phillips Electronics' "Intelligent Pill" Targets Drug Development And Treatment For Digestive Tract Diseases; Prototype Delivers Drugs Where Needed

New York, USA – At this week’s opening of the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition (Atlanta, USA, November 16-20, 2008) Philips Research will announce its new intelligent pill technology “iPill”, targeted at assisting drug development and enabling new therapies for debilitating and life-threatening digestive tract disorders such as Crohn's disease, colitis and colon cancer.

Back to news